Author

C.S. John Kim

Observed names: C S John Kim, C. S. John Kim

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5020452489

Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome

2021 · Steven M. Dotzler, C.S. John Kim, et al. · Circulation · 86

Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes

2020 · Bailey J. O’Hare, C.S. John Kim, et al. · Circulation Genomic and Precision Medicine · 40

KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

2024 · Sahej Bains, Lucilla Giammarino, et al. · European Heart Journal · 28

SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19

2023 · Daniel J. Clemens, Dan Ye, et al. · PLoS ONE · 18

Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3 -Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes

2022 · Dan Ye, Wei Zhou, et al. · Circulation Genomic and Precision Medicine · 16

Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1 -, CALM2 -, and CALM3 -Mediated Arrhythmia Disorders

2024 · Samantha K. Hamrick, C.S. John Kim, et al. · Circulation Arrhythmia and Electrophysiology · 15

Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes

2023 · Daniel J. Clemens, Dan Ye, et al. · Stem Cell Reports · 13

Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential

2022 · Marissa J. Stutzman, C.S. John Kim, et al. · Stem Cell Reports · 11

Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1–Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome

2021 · Maengjo Kim, Dan Ye, et al. · Circulation Genomic and Precision Medicine · 8

AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome

2025 · Saranda Nimani, Sahej Bains, et al. · European Heart Journal · 7

Patient-specific, re-engineered cardiomyocyte model confirms the circumstance-dependent arrhythmia risk associated with the African-specific common SCN5A polymorphism p.S1103Y: Implications for the increased sudden deaths observed in black individuals during the COVID-19 pandemic

2021 · Samantha K. Hamrick, C.S. John Kim, et al. · Heart Rhythm · 3

Works count: 11

Citation count: 243

H-index: 8

I10-index: 8